Is INmune Bio, Inc. (INMB) a Buy, Sell, or Hold?
NASDAQ : INMB
INmune Bio, Inc. — Analyst Ratings
$1.75 USD
-$0.02 (-1.13%)
- Volume
- 225.33K
- Average Volume
- 781.08K
- Market Capitalization
- $46.52M
- P/E Ratio
- -1.04
- Dividend Yield
- 0.00%
- Price Target
- $22.00
- Year High
- $2.96
- Year Low
- $1.09
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.24
Analyst Consensus Summary
Consensus Rating
Sell
9 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-92.0%
vs Current Price
Price Target
$22.00
Average TargetPrice Target Range
Lowest Target
$22.00
-92.0% DOWNSIDE
Average Target
$22.00
Median Estimate
Highest Target
$22.00
-92.0% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 9
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 6 | 2 | 1 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Scotiabank | George Farmer | $22 | $6.85 | 2024-08-22 03:35 AM | 221.2% |